CellChorus GTM brain

category

market profile

• text: Cell therapy developers need functional evidence of individual immune cell behavior over time, beyond static measurements.
• text: TIMING combines time-lapse microscopy, nanowells and AI with downstream molecular profiling.

personas

• title: Cell therapy discovery or translational science director
  pains:

  • Selecting promising CAR-T or NK cell candidates from heterogeneous populations
  • Understanding killing, migration and persistence before committing to clinical studies
• title: Biopharma assay development lead
  pains:

  • Static assays miss the timing and sequence of cell interactions
  • Comparing functional activity across thousands of cells is labor-intensive
• title: Cell therapy manufacturing and quality lead
  pains:

  • Understanding variation in functional performance between cell product batches
  • Connecting cell behavior to measurable phenotypes

icp

• text: Biotechnology and pharmaceutical developers of CAR-T, NK, TIL and antibody therapies, from emerging biotech to large pharma.
• text: Research groups with immune-cell assays and a need to connect functional behavior to single-cell molecular data.

message pillars

• text: Observe individual cell function over time.
• text: Scale analysis of immune-cell interactions with imaging and AI.
• text: Connect functional and molecular analyses.

objections

• objection: We already run flow cytometry and single-cell sequencing.
  response: TIMING can complement those modalities by linking observed function to molecular profiling; evaluate it on a representative assay.
• objection: Will the platform work for our specific cell type?
  response: The company describes multiple applications, including CAR-T, NK cells and antibodies; request assay feasibility and relevant publications.

competitors

• name: Axion BioSystems
  why: Provides live-cell functional analysis tools for research teams studying cell behavior.
• name: Sartorius
  why: Offers cell analysis and live-cell imaging products used in therapy research.
• name: Sphere Fluidics
  why: Single-cell analysis and screening platform competing for discovery assay budgets.

influencers

• name: Navin Varadarajan
  url: https://cellchorus.com/about
  why: Founder and single-cell researcher whose scientific work shapes the platform.

keywords

• dynamic single cell analysis
• CAR T cell killing assay
• single cell immune cell profiling
• time lapse cell interaction assay
• NK cell cytotoxicity assay
• cell therapy potency analysis
• single cell functional genomics

voice

• Scientific and precise
• Evidence-led
• Focused on actionable biological insight

signals

• text: A company is advancing a CAR-T, NK or TIL program and needs candidate selection data.
• text: A team seeks to link single-cell sequencing with observed cell killing or migration.

stack

• single-cell RNA sequencing
• flow cytometry
• neural network based microscopy analysis

pricing

motion

channels

• scientific publications
• conferences
• LinkedIn
• research partnerships

confidence

Founders

• name: Dan Meyer
  title: Founder
  role: Founder
  bio: Daniel Meyer is the CEO of CellChorus, the leader in providing dynamic single-cell functional analysis to the life sciences industry. Dan was the Chief Operating Officer and a board member of Genospace until its acquisition by HCA Healthcare (NYSE:HCA). He was a member of the venture capital investment teams at Arboretum Ventures and PJC.vc. Dan holds a B.A. in mathematics and economics from Middlebury College and an M.B.A. from the Tuck School of Business at Dartmouth.
• name: Navin Varadarajan
  title: Founder
  role: Founder